Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Co. stock logo
ATPC
Agape ATP
$1.47
-4.2%
$1.80
$0.90
$6.80
$73.66M-0.551.75 million shs51,628 shs
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
$3.93
-19.5%
$0.00
$0.91
$9.40
$72.53MN/A4.79 million shs2.47 million shs
CORBF
Global Cord Blood
$1.00
$0.98
$0.25
$2.00
$121.55M-0.66139,141 shsN/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$1.93
-8.8%
$1.99
$1.35
$4.07
$83.75M0.56369,005 shs406,622 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Co. stock logo
ATPC
Agape ATP
-4.97%-17.74%-26.79%+41.67%-70.60%
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
-4.13%+378.43%+15.64%+487,999,900.00%+487,999,900.00%
CORBF
Global Cord Blood
0.00%0.00%-4.76%-1.96%-16.67%
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
+17.22%+19.21%-1.86%-17.90%-37.39%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agape ATP Co. stock logo
ATPC
Agape ATP
0.4078 of 5 stars
0.05.00.00.01.10.00.0
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/AN/AN/AN/AN/AN/AN/AN/A
CORBF
Global Cord Blood
N/AN/AN/AN/AN/AN/AN/AN/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
2.2052 of 5 stars
3.53.00.00.01.11.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agape ATP Co. stock logo
ATPC
Agape ATP
0.00
N/AN/AN/A
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
0.00
N/AN/AN/A
CORBF
Global Cord Blood
0.00
N/AN/AN/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
3.00
Buy$2.8548.05% Upside

Current Analyst Ratings Breakdown

Latest BMGL, CORBF, ATPC, and QIPT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/14/2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$6.00 ➝ $4.00
5/13/2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$4.00 ➝ $1.70
(Data available from 6/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agape ATP Co. stock logo
ATPC
Agape ATP
$1.29M56.65N/AN/A$1.14 per share1.29
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
$10.05M7.22N/AN/AN/A
CORBF
Global Cord Blood
$196.12M0.62$0.71 per share1.40N/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$240.85M0.35$0.75 per share2.56$2.47 per share0.78
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agape ATP Co. stock logo
ATPC
Agape ATP
-$2.10M-$0.60N/AN/A-194.09%-74.71%-56.08%8/12/2025 (Estimated)
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/AN/A0.00N/AN/AN/AN/AN/A
CORBF
Global Cord Blood
$79.04MN/A0.00N/AN/AN/AN/AN/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
-$6.76M-$0.21N/AN/AN/A-2.90%-6.70%-2.94%8/13/2025 (Estimated)

Latest BMGL, CORBF, ATPC, and QIPT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Agape ATP Co. stock logo
ATPC
Agape ATP
N/A-$0.07N/A-$0.07N/AN/A
5/12/2025Q2 2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$0.02-$0.07-$0.09-$0.07$88.29 million$57.40 million
3/31/2025Q4 2024
Agape ATP Co. stock logo
ATPC
Agape ATP
N/A-$0.20N/A-$0.20N/A$0.36 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agape ATP Co. stock logo
ATPC
Agape ATP
N/AN/AN/AN/AN/A
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/AN/AN/AN/AN/A
CORBF
Global Cord Blood
N/AN/AN/AN/AN/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agape ATP Co. stock logo
ATPC
Agape ATP
0.05
3.59
3.53
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/AN/AN/A
CORBF
Global Cord Blood
N/AN/AN/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
0.74
1.22
0.87

Institutional Ownership

CompanyInstitutional Ownership
Agape ATP Co. stock logo
ATPC
Agape ATP
0.01%
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/A
CORBF
Global Cord Blood
N/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
42.85%

Insider Ownership

CompanyInsider Ownership
Agape ATP Co. stock logo
ATPC
Agape ATP
9.67%
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/A
CORBF
Global Cord Blood
0.50%
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
13.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agape ATP Co. stock logo
ATPC
Agape ATP
4050.01 million3.60 millionNot Optionable
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
3618.46 millionN/AN/A
CORBF
Global Cord Blood
1,200121.55 millionN/ANot Optionable
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
80043.51 million37.32 millionOptionable

Recent News About These Companies

Quipt Home Medical (QIPT) Receives a Buy from Stifel Nicolaus

New MarketBeat Followers Over Time

Media Sentiment Over Time

Agape ATP stock logo

Agape ATP NASDAQ:ATPC

$1.46 -0.07 (-4.25%)
As of 03:51 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Basel Medical Group stock logo

Basel Medical Group NASDAQ:BMGL

$3.93 -0.95 (-19.47%)
As of 03:33 PM Eastern

OUR MISSION Basel Medical transcends the role of a conventional healthcare provider. We strive for excellence in medical services and aim to serve as a beacon of hope for patients across Singapore and Southeast Asia. Our mission encompasses the four following commitments: Patient–Centered Care. We prioritize our patient’s wellbeing above all else. Innovation. We strive for excellence through innovation and expertise. Global Accessibility. We believe that quality healthcare should be universally available. Continuous Improvement. We constantly improve our services to meet evolving patient needs. With over 20 years of medical services experience, Basel Medical’s journey began with a simple commitment – to restore healthy and active lifestyles, one at a time. Today, that commitment has transformed into a vision for innovation, growth and far-reaching impact. We rely on an experienced group of medical practitioners to provide a wide spectrum of general and subspecialized orthopedic, trauma, sports medicine and neurosurgical services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, minimally invasive orthopedic procedures and other complex neurosurgical procedures. We operate our two clinics at Gleneagles Medical Centre in Singapore and currently have five medical practitioners practicing with Basel Medical (together with its subsidiaries, the “Group”), comprising four orthopedic specialists and one neurosurgery specialist. The services provided by our clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine and neurological conditions and our clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services, while more complex surgical procedures are performed at operating theaters of other hospitals with such facilities. Our Group has a patient-oriented philosophy of providing personalized, quality and integrated medical care. We aim to be a one-stop integrated healthcare provider for all musculoskeletal-related medical care, including post-surgery rehabilitation services such as physiotherapy as well as other ancillary services such as pain management. Within the next 12 to 18 months, we intend to actively seek acquisition and collaboration partners in Singapore and Malaysia. Our acquisition and collaboration targets include general practitioner (GP) clinics and specialist clinics that complement our orthopedic services, particularly those focused on the musculoskeletal system, aging treatments, physiotherapy and occupational therapists. Our goal is to become an internationally known medical services provider in the Southeast Asian market, with a presence in at least four Southeast Asia countries (potentially covering Singapore, Malaysia, Indonesia and Thailand) within the next three years. As of the date of this prospectus, we have not identified such targets. Basel Medical was incorporated in the BVI on August 10, 2023 with registered number 2129740 as a BVI business company with liability limited by shares. Our BVI registered office is located at Kingston Chambers, PO Box 173, Road Town, Tortola, British Virgin Islands VG1110. Our principal executive offices are located in Singapore at 6 Napier Road, Unit #02-10/11 Gleneagles Medical Centre, Singapore. Our agent for service of process in the United States is Puglisi & Associates at 850 Library Avenue, Suite 204, Newark, Delaware.

Global Cord Blood NYSE:CORBF

$1.00 0.00 (0.00%)
As of 06/4/2025

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Quipt Home Medical stock logo

Quipt Home Medical NASDAQ:QIPT

$1.92 -0.19 (-8.77%)
As of 03:52 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.